Labusek, Nicole
Ghari, Parnian
Mouloud, Yanis
Köster, Christian
Diesterbeck, Eva
Hadamitzky, Martin
Felderhoff-Müser, Ursula
Bendix, Ivo
Giebel, Bernd
Herz, Josephine
Funding for this research was provided by:
European Society for Paediatric Research (RGP2022-YISUG-02/04)
Horizon 2020 (874721, PREMSTEM)
European Regional Development Fund (2014–2020)
ERA-NET EuroTransBio 11 EVTrust (031B0332B)
Else Kröner-Fresenius-Stiftung (2018_A113)
Universitätsklinikum Essen
Article History
Received: 8 September 2023
Accepted: 16 November 2023
First Online: 27 November 2023
Declarations
:
: Human MSCs were initially raised from bone marrow samples of healthy donors after informed consent according to the Declaration of Helsinki. Animal experiments were performed in accordance with the Animal Research Reporting of in Vivo Experiments (ARRIVE) guidelines with governmental approval by the State Agency for Nature, Environment and Consumer Protection North Rhine-Westphalia.
: Not applicable.
: BG is a scientific advisory board member of Innovex Therapeutics SL, Mursla Ltd and PL BioScience. He is a founding director of Exosla Ltd. All other authors report no conflicts of interest.